Endothelial cell protection

"Endothelial cell protection" is not the name of a specific molecule or receptor but rather describes a set of biological processes that preserve the structure and function of the vascular endothelium. The endothelium forms a critical barrier between blood and tissues, regulating permeability, inflammation, coagulation, vasodilation/vasoconstriction, leukocyte adhesion/migration, and angiogenesis. Protective mechanisms include maintaining tight junctions via proteins like VE-cadherin; suppressing inflammatory responses; preventing apoptosis through pathways involving high-density lipoproteins (HDL), which inhibit caspase activity; activating antiapoptotic kinases such as Akt; promoting nitric oxide production via eNOS activation for vasodilation; repairing membrane damage with molecules like annexins; and modulating immune interactions. Disruption or dysfunction in these protective mechanisms contributes to diseases such as atherosclerosis, edema formation due to increased permeability during inflammation or injury, cancer progression through altered angiogenesis regulation, and other cardiovascular pathologies. "Endothelial cell protection" is therefore not itself a druggable target but an important therapeutic goal achieved by targeting specific molecular pathways within endothelial cells.[1][2][3][4]

Other names

Endothelial protectionEndothelial cell barrier functionEndothelial integrityVascular endothelium protection

Enhancement or preservation of endothelial cell survival by inhibiting apoptosis pathways such as caspase activation[1] Activation of antiapoptotic kinases like Akt to maintain mitochondrial integrity[1]